These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 11494751

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. FIELD study.
    Rees A.
    Diabet Med; 2006 Jul; 23 Suppl 3():6-12. PubMed ID: 16805876
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cochleovestibular disorders and hyperlipidemia. A controlled trial with fenofibrate.
    Torossian F, Laredo C.
    Monogr Atheroscler; 1986 Jul; 14():222-9. PubMed ID: 3526130
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fenofibrate and cardiovascular risk: a synopsis and commentary on (FIELD).
    Bailey CJ.
    Diabet Med; 2006 Feb; 23(2):109-12. PubMed ID: 16433706
    [No Abstract] [Full Text] [Related]

  • 8. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
    Steiner G.
    Am J Cardiol; 2008 Dec 22; 102(12A):28L-33L. PubMed ID: 19084087
    [Abstract] [Full Text] [Related]

  • 9. Reducing ocular damage in type 2 diabetes: the FIELD study shows fenofibrate benefits.
    Cardiovasc J Afr; 2007 Dec 22; 18(6):400. PubMed ID: 18092120
    [No Abstract] [Full Text] [Related]

  • 10. Statins and fibrates in the management of diabetic dyslipidemia.
    Durrington P.
    Diabet Med; 1997 Jul 22; 14(7):513-6. PubMed ID: 9223386
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of coronary artery disease in a patient with adult-onset diabetes mellitus].
    Syvänne M.
    Duodecim; 1999 Jul 22; 115(10):1167-73. PubMed ID: 11877856
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatments for cardiovascular risk factors and screening for coronary artery disease in type 2 diabetes mellitus].
    Ruiz J, Egli M, Gianinazzi F, Izzo F, Voeffray Favre AC, Rossi I, Bodenman P.
    Rev Med Suisse; 2010 Jun 09; 6(252):1176-8, 1180-1. PubMed ID: 20614751
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dyslipidemia in type 2 diabetes.
    Krauss RM, Siri PW.
    Med Clin North Am; 2004 Jul 09; 88(4):897-909, x. PubMed ID: 15308384
    [Abstract] [Full Text] [Related]

  • 19. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid.
    Cardiovasc J Afr; 2008 Jul 09; 19(3):171-2. PubMed ID: 18568186
    [No Abstract] [Full Text] [Related]

  • 20. Rationale for new American Diabetes Association Guidelines: are national cholesterol education program goals adequate for the patient with diabetes mellitus?
    Haffner S.
    Am J Cardiol; 2005 Aug 22; 96(4A):33E-36E. PubMed ID: 16098841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.